Leafy Tunnel is a venture capital firm investing in psychedelic medicine to address mental health and pain disorders. The firm closed its first fund of $30 million in January 2022 and has already made 7 out of the estimated 15 investments the fund will make.
Leafy Tunnel
“Our mission is to back teams that aim to maximise the potential of alternative medicine with a focus on providing relief from pain, physical and mental stress whilst improving the quality of life for both patients and their families.”
Key staff
- Nikolay Tretiyakov – Co-founder
- Bek Muslimov – Co-founder
- Andrey Makiyevskiy – Principal
Activities
B2B
Investor
Explore more company info with a Tree membership
📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates
Company News
Leafy Tunnel announces the first closing of its medical cannabis and psychedelics fund (Cision PR, 31 January 2022)Leafy Tunnel, a UK-based VC firm, has announced the closing of its $30 million fund. The money will allow them to invest in up to 15 companies, of which it has already made 7 investments (e.g. Beckley Psytech, Maya Health).